T. Rowe Price Group, Inc. (TROW) Balance Sheet
As of 2026-06-30 (10-Q), T. Rowe Price Group, Inc. (TROW) reported total assets of $15.4B, total liabilities of $3.2B and shareholders' equity of $11.0B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $3.2B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TROWT. Rowe Price Group, Inc.Follow TROW — free
—
Price chart with a free account
- Market cap
- 22.2B
- P/E TTM
- 10.5
- Dividend yield
- 4.9%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.74 | 0.81 | 0.90 | 0.88 | 1.40 | 1.51 | 1.17 | 1.20 | 1.90 | 1.43 | 1.78 | 2.15 | 1.52 | 1.76 | 2.07 | 2.65 | 3.38 | 3.23 | |
| Total assets | 3.21 | 3.64 | 3.77 | 4.20 | 5.03 | 5.64 | 5.11 | 6.23 | 7.54 | 7.69 | 9.33 | 10.66 | 12.51 | 11.64 | 12.28 | 13.47 | 14.34 | 15.36 | |
| Total liabilities | 0.33 | 0.35 | 0.35 | 0.36 | 0.22 | 0.25 | 0.34 | 0.53 | 0.72 | 0.82 | 1.11 | 1.39 | 2.26 | 1.96 | 1.99 | 2.02 | 2.29 | 3.18 | |
| Shareholders' equity | 2.88 | 3.30 | 3.42 | 3.85 | 4.82 | 5.40 | 4.76 | 5.01 | 5.82 | 6.12 | 7.10 | 7.71 | 9.02 | 8.84 | 9.51 | 10.35 | 10.86 | 11.00 |
USD billions · SEC XBRL
T. Rowe Price Group, Inc. — questions
- How much cash does T. Rowe Price Group, Inc. have?
- $3.2B in cash and cash equivalents as of 2026-06-30.
- What are T. Rowe Price Group, Inc.'s total assets?
- $15.4B as of 2026-06-30.
- What is T. Rowe Price Group, Inc.'s shareholders' equity?
- $11.0B as of 2026-06-30.
Every figure on this page comes from T. Rowe Price Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.